New weapon tested in fight against advanced cancers

NCT ID NCT05123482

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing a new drug called AZD8205, both by itself and combined with other cancer drugs, for people with advanced solid tumors that have spread or returned. The main goals are to find safe doses and see if the treatments can shrink tumors. It is enrolling adults with specific advanced cancers, including breast, ovarian, lung, and biliary tract cancers, who have already tried standard treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
COMPLETED

Duarte, California, 91010, United States
Research Site
COMPLETED

Irvine, California, 92618, United States
Research Site
RECRUITING

Santa Monica, California, 90404, United States
Research Site
RECRUITING

Santa Rosa, California, 95403, United States
Research Site
ACTIVE_NOT_RECRUITING

Shreveport, Louisiana, 71103, United States
Research Site
RECRUITING

Baltimore, Maryland, 21231, United States
Research Site
RECRUITING

Boston, Massachusetts, 02215, United States
Research Site
RECRUITING

St Louis, Missouri, 63110, United States
Research Site
RECRUITING

Albuquerque, New Mexico, 87109, United States
Research Site
RECRUITING

Commack, New York, 11725, United States
Research Site
WITHDRAWN

New York, New York, 10029, United States
Research Site
RECRUITING

Charlotte, North Carolina, 28204, United States
Research Site
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
Research Site
RECRUITING

Houston, Texas, 77030, United States
Research Site
TERMINATED

Clayton, 3168, Australia
Research Site
RECRUITING

Melbourne, VIC 3000, Australia
Research Site
RECRUITING

Nedlands, 6009, Australia
Research Site
RECRUITING

Anderlecht, 1070, Belgium
Research Site
RECRUITING

Leuven, 3000, Belgium
Research Site
RECRUITING

Calgary, Alberta, T2N 5G2, Canada
Research Site
RECRUITING

Vancouver, British Columbia, V5Z 4E6, Canada
Research Site
RECRUITING

Ottawa, Ontario, K1H 8L6, Canada
Research Site
RECRUITING

Toronto, Ontario, M5G 2M9, Canada
Research Site
COMPLETED

Montreal, Quebec, H4A 3J1, Canada
Research Site
COMPLETED

Beijing, 100142, China
Research Site
RECRUITING

Beijing, 100142, China
Research Site
TERMINATED

Changsha, 410013, China
Research Site
RECRUITING

Changsha, 410013, China
Research Site
RECRUITING

Chongqing, 400030, China
Research Site
COMPLETED

Guangzhou, 510060, China
Research Site
RECRUITING

Kunming, 650118, China
Research Site
RECRUITING

Shandong, China
Research Site
WITHDRAWN

Budapest, 1062, Hungary
Research Site
RECRUITING

Budapest, 1082, Hungary
Research Site
RECRUITING

Budapest, 1122, Hungary
Research Site
RECRUITING

Milan, 20141, Italy
Research Site
RECRUITING

Modena, 41125, Italy
Research Site
RECRUITING

Roma, 00168, Italy
Research Site
RECRUITING

Rozzano, 20089, Italy
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Hidaka-shi, 350-1298, Japan
Research Site
RECRUITING

Kashiwa, 277-8577, Japan
Research Site
RECRUITING

Kōtoku, 135-8550, Japan
Research Site
RECRUITING

Kurume-shi, 830-0011, Japan
Research Site
RECRUITING

Sunto-gun, 411-8777, Japan
Research Site
RECRUITING

Amsterdam, 1066 CX, Netherlands
Research Site
RECRUITING

Gdansk, 80-214, Poland
Research Site
RECRUITING

Warsaw, 02-781, Poland
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
RECRUITING

Seoul, 05505, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Barcelona, 8035, Spain
Research Site
RECRUITING

L'Hospitalet de Llobregat, 08908, Spain
Research Site
RECRUITING

Madrid, 28027, Spain
Research Site
RECRUITING

Málaga, 29010, Spain
Research Site
RECRUITING

Pamplona, 31008, Spain
Research Site
NOT_YET_RECRUITING

Taichung, 40705, Taiwan
Research Site
RECRUITING

Tainan, 704, Taiwan
Research Site
RECRUITING

Taipei, 10002, Taiwan
Research Site
RECRUITING

Taipei, 11259, Taiwan
Research Site
RECRUITING

Taoyuan District, 333, Taiwan
Research Site
RECRUITING

Bangkok, 10330, Thailand
Research Site
RECRUITING

Chiang Mai, 50200, Thailand
Research Site
RECRUITING

Cambridge, CB2 0XY, United Kingdom
Research Site
RECRUITING

Cardiff, CF14 2TL, United Kingdom
Research Site
RECRUITING

London, EC1A 7BE, United Kingdom

Conditions

Explore the condition pages connected to this study.

BILIARY TRACT CARCINOMA BREAST CANCER ENDOMETRIAL CANCER OVARIAN CANCER SQUAMOUS NON-SMALL-CELL LUNG CANCER